# Penn Pharmaceutical Services Limited - Inspection Records

Source: https://www.keypedia.com/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343

> Inspection records and compliance data for Penn Pharmaceutical Services Limited in Tredegar. 8 FDA inspections on record (1 OAI), last inspected April 01, 2022.

---

## Details

- Name: Penn Pharmaceutical Services Limited
- FEI Number: 1000370240
- Address Line 1: Unit 23-24, Tafarnaubach Industrial Estate
- City: Tredegar
- Country Name: United Kingdom
- Address: Unit 23-24, Tafarnaubach Industrial Estate, Tredegar, United Kingdom
- Country: United Kingdom

## Related Documents

- FDA Inspection 1181809 - Penn Pharmaceutical Services Limited - 2022-04-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2022
- FDA Inspection 1081935 - Penn Pharmaceutical Services Limited - 2019-02-01 — classification: No Action Indicated (NAI), source: FDA, date: February 1, 2019
- FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01 — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01 — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- FDA Inspection 1004548 - Penn Pharmaceutical Services Limited - 2017-03-01 — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2017
- FDA Inspection 1063598 - Penn Pharmaceutical Services Limited - 2017-01-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2017
- FDA Inspection 979658 - Penn Pharmaceutical Services Limited - 2016-07-08 — classification: No Action Indicated (NAI), source: FDA, date: July 8, 2016
- [FDA Inspection 979658 - Penn Pharmaceutical Services Limited - 2016-07-08](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/f22da230-3242-4280-8173-4334b0f4e6c4) — classification: No Action Indicated (NAI), source: FDA, date: July 8, 2016
- [FDA Inspection 822276 - Penn Pharmaceutical Services Limited - 2013-02-07](https://www.keypedia.com/records/fda_inspections/penn-pharmaceutical-services-limited/56d9c8ff-c300-48db-9468-d0365cc23d38) — classification: Official Action Indicated (OAI), source: FDA, date: February 7, 2013
- FDA Inspection 822276 - Penn Pharmaceutical Services Limited - 2013-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2013

## Related Companies

- [Jianerkang Medical Co., Ltd](https://www.keypedia.com/companies/jianerkang-medical-co-ltd/4cd5cca8-7e53-45e0-9fe5-42981a741cd0)
- [Century Pharmaceuticals, Inc.](https://www.keypedia.com/companies/century-pharmaceuticals-inc/d3898136-aa03-4edc-b005-44709b7f4c67)
- [Amgen Europe BV](https://www.keypedia.com/companies/amgen-europe-bv/869a9ce4-c741-4aec-b25c-d68d881594a7)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)
- [Reckitt Benckiser Healthcare Manufacturing (Thailand) Ltd.](https://www.keypedia.com/companies/reckitt-benckiser-healthcare-manufacturing-thailand-ltd/016a0f4a-a4f3-47c7-8efa-58dc8165038d)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/a58b7a37-69a3-45d1-a590-72294e5e7a17)
- [Combe Products, Inc.](https://www.keypedia.com/companies/combe-products-inc/a6e98ba4-74cb-437e-b564-11c7ae66df81)
- [Summit Biosciences Inc.](https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976)
- [Colgate-Palmolive Company](https://www.keypedia.com/companies/colgate-palmolive-company/7db665f6-094f-4de5-bf3b-c2528e2a223b)
- [Contract Pharmacal Corporation](https://www.keypedia.com/companies/contract-pharmacal-corporation/97b30a3a-ecc8-4ffd-b641-fc8b51cb24d8)